22/05/2024  21:27:32 Chg. - Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
210.0000USD - 30
Chiffrre d'affaires: 6,300
-Bid taille: - -Ask la taille: - 18.28 Mrd.USD - -

Description de l'entreprise

Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
 

Conseil d'administration & Conseil de surveillance

PDG
Dr. Joachim Kreuzburg
Conseil d'administration
Alexandra Gatzemeyer, Dr. René Fáber
Conseil de surveillance
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey
 

Données de l'entreprise

Nom: Sartorius Stedim Biotech SA
Adresse: Avenue de Jouques - CS 91051,F-13781 Aubagne Cedex
Téléphone: +33-442-84-5600
Fax: +33-442-84-5619
Courriel: info@sartorius-stedim.com
Internet: https://www.sartorius.com/en/company/about-sartorius-stedim-biotech-sa
Industrie: Biotechnology
Secteur: Biotechnology
Sous-secteur: Biotechnology
Fin de l'exercice financier: 31/12
Flotte libre: 26.20%
IPO date: -

Relations avec les investisseurs

Nom: Petra Kirchhoff
Téléphone IR: +49-551-308-1686
IR-Fax: -
E-mail IR: petra.kirchhoff@sartorius.com

Calendrier de l'entreprise

CW 29 | 19/07/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 17/10/2024 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Sartorius AG
 
73.60%
free float
 
26.40%